Management of Autoimmune ILD

Elizabeth R. Volkmann

Statin Myopathy

ACR Convergence 2022 Coverage

L. Christopher-Stine

Pulmonary Complications of Rheumatic Diseases

National Jewish Health

J. Solomon

Co-Management of CTD-ILD: A Rheumatology and Pulmonology Perspective

West Virginia State Rheumatology Society

R. Aggarwal, D. Sullivan

Rheumatology Lung Disease Panel

Michigan Medicine

K. M Chan, D. Roofeh, B. Wang

ATS 2024 Insights: Management Decisions After Early Detection of CTD…

Insights from 2024 ATS Annual Meeting

S. Matson

SAPHO

Cleveland Clinic Rheumatology

A. Brown

New and Emerging Treatments in Fibrosing Skin Disorders

Cleveland Clinic Rheumatology

S. Chatterjee

Combining Systemic Therapies in Connective Tissue Diseases

Carole Bitar

The Condition Formally Known as Benign Joint Hypermobility Syndrome …

Matthew Carroll

Loeys-Dietz Syndrome: The Next 10 Years

Marfan Foundation

Marfan 101: What Systems Does it Affect? How to Make Diagnosis and T…

Marfan Foundation

Instructive Cases in Dermal Hypertrophy: Benign Neoplasms I

Jacqueline Junkins-Hopkins

Lung Transplant and Rheumatic Diseases

Cleveland Clinic Rheumatology

S. Sehgal

Wise Use of ANA Testing

Matthew Carroll

What is MCTD? The Great Debate With Dr. Christopher-Stine

RheumNow

L. Christopher-Stine

Duputryen's Contracture

Keck School of Medicine of USC

D. Arkfeld

Interstitial Lung Disease in Immune-Mediated Inflammatory Diseases

Cleveland Clinic Rheumatology

J. Parambil

EADV 2023 Insights: How to Avoid Mistreatment of Neoplastic Lesions

EADV 2023 Insights

I. Zalaudek

The Condition Formally Known as Benign Joint Hypermobility Syndrome …

Matthew Carroll